Global Influenza Virus Vaccine (H1N1) Market Insights and Forecast to 2028

Global Influenza Virus Vaccine (H1N1) Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Influenza Virus Vaccine (H1N1) Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Market by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Virus Vaccine (H1N1) Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Virus Vaccine (H1N1) Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Virus Vaccine (H1N1) Sales by Region
2.4.1 Global Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Virus Vaccine (H1N1) by Region (2023-2028)
2.5 Global Influenza Virus Vaccine (H1N1) Revenue by Region
2.5.1 Global Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022)
2.5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers
3.1.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Virus Vaccine (H1N1) in 2021
3.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers
3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2021
3.3 Global Influenza Virus Vaccine (H1N1) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Virus Vaccine (H1N1) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Virus Vaccine (H1N1) Sales by Type
4.1.1 Global Influenza Virus Vaccine (H1N1) Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Virus Vaccine (H1N1) Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
4.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type
4.2.1 Global Influenza Virus Vaccine (H1N1) Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Virus Vaccine (H1N1) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Virus Vaccine (H1N1) Price by Type
4.3.1 Global Influenza Virus Vaccine (H1N1) Price by Type (2017-2022)
4.3.2 Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza Virus Vaccine (H1N1) Sales by Application
5.1.1 Global Influenza Virus Vaccine (H1N1) Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Virus Vaccine (H1N1) Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application
5.2.1 Global Influenza Virus Vaccine (H1N1) Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Virus Vaccine (H1N1) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Virus Vaccine (H1N1) Price by Application
5.3.1 Global Influenza Virus Vaccine (H1N1) Price by Application (2017-2022)
5.3.2 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza Virus Vaccine (H1N1) Market Size by Type
6.1.1 North America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
6.1.2 North America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
6.2 North America Influenza Virus Vaccine (H1N1) Market Size by Application
6.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
6.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
6.3 North America Influenza Virus Vaccine (H1N1) Market Size by Country
6.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
6.3.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Virus Vaccine (H1N1) Market Size by Type
7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
7.2 Europe Influenza Virus Vaccine (H1N1) Market Size by Application
7.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
7.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
7.3 Europe Influenza Virus Vaccine (H1N1) Market Size by Country
7.3.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
7.3.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Type
8.1.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Application
8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region
8.3.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Virus Vaccine (H1N1) Market Size by Type
9.1.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
9.1.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
9.2 Latin America Influenza Virus Vaccine (H1N1) Market Size by Application
9.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
9.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
9.3 Latin America Influenza Virus Vaccine (H1N1) Market Size by Country
9.3.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
9.3.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Type
10.1.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Application
10.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Country
10.3.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 NVS(Novartis)
11.2.1 NVS(Novartis) Corporation Information
11.2.2 NVS(Novartis) Overview
11.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NVS(Novartis) Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Medimmune
11.4.1 Medimmune Corporation Information
11.4.2 Medimmune Overview
11.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medimmune Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medimmune Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Overview
11.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Recent Developments
11.7 Beijing Kexing Bio-Vaccine
11.7.1 Beijing Kexing Bio-Vaccine Corporation Information
11.7.2 Beijing Kexing Bio-Vaccine Overview
11.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Kexing Bio-Vaccine Recent Developments
11.8 Hualan Bio-Vaccine
11.8.1 Hualan Bio-Vaccine Corporation Information
11.8.2 Hualan Bio-Vaccine Overview
11.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hualan Bio-Vaccine Recent Developments
11.9 Changchun Changsheng Bio-Technology
11.9.1 Changchun Changsheng Bio-Technology Corporation Information
11.9.2 Changchun Changsheng Bio-Technology Overview
11.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Changchun Changsheng Bio-Technology Recent Developments
11.10 Beijing Tiantan Bio-Products
11.10.1 Beijing Tiantan Bio-Products Corporation Information
11.10.2 Beijing Tiantan Bio-Products Overview
11.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Beijing Tiantan Bio-Products Recent Developments
11.11 Jiangsu Yanshen Bio-Technology
11.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
11.11.2 Jiangsu Yanshen Bio-Technology Overview
11.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Yanshen Bio-Technology Recent Developments
11.12 Zhejiang Tianyuan Bio-Pharmaceutical
11.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
11.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Overview
11.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
11.13 Dalian Yalifeng Bio-Pharmaceutical
11.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
11.13.2 Dalian Yalifeng Bio-Pharmaceutical Overview
11.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments
11.14 Sinopharm
11.14.1 Sinopharm Corporation Information
11.14.2 Sinopharm Overview
11.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sinopharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Virus Vaccine (H1N1) Industry Chain Analysis
12.2 Influenza Virus Vaccine (H1N1) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Virus Vaccine (H1N1) Production Mode & Process
12.4 Influenza Virus Vaccine (H1N1) Sales and Marketing
12.4.1 Influenza Virus Vaccine (H1N1) Sales Channels
12.4.2 Influenza Virus Vaccine (H1N1) Distributors
12.5 Influenza Virus Vaccine (H1N1) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Virus Vaccine (H1N1) Industry Trends
13.2 Influenza Virus Vaccine (H1N1) Market Drivers
13.3 Influenza Virus Vaccine (H1N1) Market Challenges
13.4 Influenza Virus Vaccine (H1N1) Market Restraints
14 Key Findings in The Global Influenza Virus Vaccine (H1N1) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Vaccine
Table 3. Major Manufacturers of Nasal Spray Vaccine
Table 4. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
Table 7. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
Table 8. Global Influenza Virus Vaccine (H1N1) Sales by Region (2023-2028) & (K Doses)
Table 9. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2023-2028)
Table 10. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)
Table 12. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2023-2028)
Table 14. Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2017-2022)
Table 16. Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2017-2022)
Table 18. Influenza Virus Vaccine (H1N1) Price by Manufacturers (2017-2022) &(US$/Dose)
Table 19. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2021)
Table 21. Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza Virus Vaccine (H1N1) Product Offered
Table 23. Date of Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 26. Global Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
Table 27. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2017-2022)
Table 28. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2023-2028)
Table 29. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2017-2022)
Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2023-2028)
Table 33. Influenza Virus Vaccine (H1N1) Price by Type (2017-2022) & (US$/Dose)
Table 34. Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2023-2028) & (US$/Dose)
Table 35. Global Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 36. Global Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
Table 37. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2017-2022)
Table 38. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2023-2028)
Table 39. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2017-2022)
Table 42. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2023-2028)
Table 43. Influenza Virus Vaccine (H1N1) Price by Application (2017-2022) & (US$/Dose)
Table 44. Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2023-2028) & (US$/Dose)
Table 45. North America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 46. North America Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
Table 47. North America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 50. North America Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
Table 51. North America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 54. North America Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
Table 55. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
Table 105. CSL Corporation Information
Table 106. CSL Description and Major Businesses
Table 107. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 108. CSL Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. CSL Recent Developments
Table 110. NVS(Novartis) Corporation Information
Table 111. NVS(Novartis) Description and Major Businesses
Table 112. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 113. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. NVS(Novartis) Recent Developments
Table 115. Sanofi Pasteur Corporation Information
Table 116. Sanofi Pasteur Description and Major Businesses
Table 117. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 118. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi Pasteur Recent Developments
Table 120. Medimmune Corporation Information
Table 121. Medimmune Description and Major Businesses
Table 122. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 123. Medimmune Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Medimmune Recent Developments
Table 125. GSK Corporation Information
Table 126. GSK Description and Major Businesses
Table 127. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 128. GSK Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GSK Recent Developments
Table 130. Baxter Corporation Information
Table 131. Baxter Description and Major Businesses
Table 132. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 133. Baxter Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Baxter Recent Developments
Table 135. Beijing Kexing Bio-Vaccine Corporation Information
Table 136. Beijing Kexing Bio-Vaccine Description and Major Businesses
Table 137. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 138. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Beijing Kexing Bio-Vaccine Recent Developments
Table 140. Hualan Bio-Vaccine Corporation Information
Table 141. Hualan Bio-Vaccine Description and Major Businesses
Table 142. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 143. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Hualan Bio-Vaccine Recent Developments
Table 145. Changchun Changsheng Bio-Technology Corporation Information
Table 146. Changchun Changsheng Bio-Technology Description and Major Businesses
Table 147. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 148. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Changchun Changsheng Bio-Technology Recent Developments
Table 150. Beijing Tiantan Bio-Products Corporation Information
Table 151. Beijing Tiantan Bio-Products Description and Major Businesses
Table 152. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 153. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Beijing Tiantan Bio-Products Recent Developments
Table 155. Jiangsu Yanshen Bio-Technology Corporation Information
Table 156. Jiangsu Yanshen Bio-Technology Description and Major Businesses
Table 157. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 158. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Jiangsu Yanshen Bio-Technology Recent Developments
Table 160. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
Table 161. Zhejiang Tianyuan Bio-Pharmaceutical Description and Major Businesses
Table 162. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 163. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
Table 165. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
Table 166. Dalian Yalifeng Bio-Pharmaceutical Description and Major Businesses
Table 167. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs